Trial Profile
A Phase 1 Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jan 2019
Price :
$35
*
At a glance
- Drugs Ketorolac (Primary)
- Indications Acute pain; Migraine; Postoperative pain
- Focus Pharmacokinetics
- Sponsors American Regent; Luitpold Pharmaceuticals
- 07 Jun 2011 New trial record